Asthma Pathophysiology and the Scientific Rationale for Combination Therapy

ISSN： 1539-6304

Source： Allergy and Asthma Proceedings, Vol.23, Iss.4, 2002-07, pp. : 247-251

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination Therapy of Bronchial Asthma

By Nelson Harold S.

Allergy and Asthma Proceedings, Vol. 22, Iss. 4, 2001-07 ,pp. : 217-220

OceanSide Publications, Inc

Access to resources Recommend Favorite

Clinical Implications of Combination Therapy on the Future of Asthma Management

By Simon Ronald A.

Allergy and Asthma Proceedings, Vol. 24, Iss. 2, 2003-03 ,pp. : 91-93

OceanSide Publications, Inc

Access to resources Recommend Favorite

Resistance to Chemotherapy and Molecularly Targeted Therapies: Rationale for Combination Therapy in Malignant Melanoma

Current Molecular Medicine, Vol. 11, Iss. 7, 2011-10 ,pp. : 553-563

Bentham Science Publishers

Access to resources Recommend Favorite

Understanding Asthma Pathophysiology

By Fireman Philip

Allergy and Asthma Proceedings, Vol. 24, Iss. 2, 2003-03 ,pp. : 79-83

OceanSide Publications, Inc

Access to resources Recommend Favorite

Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapy

By Hagiwara May Delea Thomas E. Stanford Richard H. Stempel David A.

Allergy and Asthma Proceedings, Vol. 31, Iss. 3, 2010-05 ,pp. : 203-210

OceanSide Publications, Inc

Access to resources Recommend Favorite